Thank you for your interest in pursuing a career with us at BenevolentAI, although we don’t have a live role for this position, we frequently hire DMPK Scientists. By applying to our talent pool, we will alert you as soon as we start hiring for this position again.
We actively encourage applications at all levels from Junior through to Director/VP.
With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
The DMPK lab team performs a range of assays and reports fundamental DMPK assay results and parameters. As part of the DMPK lab team, you may take responsibility for an area of expertise (eg bioanalysis, enzyme phenotyping, metabolic stability in microsomes and hepatocytes, supporting IVIVC).
You could also potentially work within the DMPK project rep team to support our expanding discovery and development pipeline. This would involve engaging fully in cross-functional project teams to profile lead compounds/drug candidates, take responsibility for IVIVC, PK/PD and PBPK modelling, and ultimately to translate from in vitro data and in vivo non-clinical studies to predict pharmacokinetics, efficacy and safety in patients.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. BenevolentAI has a consistently proven track record of scientifically validated discoveries. The BenevolentAI Platform™ powers a growing in-house pipeline of over 20 disease programmes, spanning from target discovery to clinical studies, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey.
Head over to our Glassdoor page to learn about our benefits, culture and to find out what our team thinks about life at Benevolent. You can also find out more about us on LinkedIn and Twitter.
